100 Microns and 170 Microns Segment to Dominate Middle East & Africa Blood Filter Market during 2019–2028

According to a new market research study on “Middle East & Africa Blood Filter Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Material, Application, and End User,” is expected to reach US$ 37,333.72 thousand by 2028 from US$ 29,338.38 thousand in 2021. The market is estimated to grow at a CAGR of 3.5% from 2021 to 2028. Technological advancement in blood filters is the major factor driving the growth of the Middle East & Africa blood filter market. However, product recalls may hinder the growth of Middle East & Africa blood filter market. The report provides trends prevailing in the Middle East & Africa blood filter market along with the drivers and restraints pertaining to the market growth.

Countries in the Middle East have also widely affected the socio-economic condition by the COVID-19 pandemic. The challenges posed by the COVID-19 pandemic and the degrading economics would be particularly frightening for the region's fragile and conflict-torn states, such as Iraq, Sudan, South Africa, and Yemen, as they are likely to result in low imports due to disruptions in the global trade, further caused the shortages of medical supplies and other goods in the Middle East and Africa. This factor is also resulting in significant price hikes in the region. The demand for blood filter systems in the pandemic is tending from the outbreak of Covid-19, now the medical devices companies are working on developing strategies to aid in treatment procedure of COVID-19. Further, the adoption of plasma therapy for treating COVID patients is contributing to the blood filter market progress. The UAE was reported to be adopting convalescent plasma (CP) therapy that involves taking antiviral antibodies from the blood of people recovered from the disease and donating them to the critically ill. With antivirals still undergoing human trials, the CP therapy gained huge importance in the region in 2020. In April 2020, medics at Sheikh Khalifa Medical City in Abu Dhabi treated a patient for the first time with the plasma of an Emirati who had recovered from the virus. In the UAE, the CPT was used in Rashid Hospital to treat more than 170 COVID patients with promising results. The use of CPT led to the elevated demand for blood filters and other blood filtration devices to separate the blood components.

The Middle East & Africa blood filter market is segmented into product, application, material, end user, and country. The Middle East & Africa blood filter market, by product, is segmented into 40 Microns and 70 Microns, 100 Microns and 170 Microns, and others. The 100 microns to 170 microns segment held the largest share of the market in 2021. The Middle East & Africa blood filter market, by material, is segmented into polycarbonate, polyester, ABS, and others. The polyester segment held the largest share of the market in 2021. The Middle East & Africa blood filter market, by application, is segmented into blood processing and blood transfusion. The blood transfusion segment held the largest share of the market in 2021. On the basis of blood transfusion, the market is further segmented into whole blood, red cell, and plasma and platelet filtration. The plasma and platelet filtration segment accounts for largest market share in the 2021. Based on end user, the Middle East & Africa blood filter market is segmented blood banks, hospitals, and others. The blood banks segment held the largest share of the market in 2021. Similarly, based on country, the market is bifurcated into Saudi Arabia, South Africa, UAE, and rest of Middle East & Africa. The rest of Middle East & Africa contributed a substantial share in 2021. 

Fresenius Kabi AG; Haemonetics Corporation; Infomed SA; KANEKA CORPORATION; Macopharma; Sefar AG; and Shandong Zhongbaokang Medical Implements Co., Ltd are among the leading companies in the Middle East & Africa Blood Filter Market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, ExThera Medical’s Seraph 100 Microbind Affinity Filter (Seraph 100) is distributed in Europe by Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases. The two companies signed a co-marketing and distribution agreement earlier this year

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com